Vicadrostat not checked

Boehringer Ingelheim · BI 690517

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
5 active
18 in total · 10 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Heart Failure (2 trials), Kidney Disease, Chronic, Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
Main trialPhase 3
“This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study. The study is open to people who take other medicines called angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB). People who already take empagliflozin or any other sodium-glucose cotransporter-2 inhibitor (SGLT2i) can also join. The study is also open to people who currently do not take any of these treatments. The purpose of this study is to find out whether a medicine called BI 690517 helps people with…”In the company’s words, NCT06531824 on ClinicalTrials.gov
Other names
BI 690517

Other drugs for Heart Failure

All 42 drugs for Heart Failure

Coming up5

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials18

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 31 Dec 2026 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3Recruiting 22 May 2028 A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Phase 3Recruiting 4 Feb 2029 A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Phase 3Recruiting 14 Dec 2029 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Phase 1Recruiting 11 Dec 2026 A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat / Empagliflozin Tablets Are Taken up in the Body
Phase 2Completed 19 Jun 2023 A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease
Phase 2Completed 14 Aug 2026 A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
Phase 1Completed 12 Dec 2016 Single Rising Dose Study of BI 690517 in Healthy Volunteers
Phase 1Completed 13 Oct 2017 This Study is Done in Healthy Chinese and Japanese Volunteers; it Looks at How BI 690517 is Taken up in the Body and How Well it is Tolerated
Phase 1Completed 24 Nov 2017 This Study Tests How Different Doses of BI 690517 Are Taken up in the Body of Healthy Men. The Study Also Looks at How Food Influences the Amount of BI 690517 in the Blood
Phase 1Completed 31 Jan 2019 A Study in Healthy Japanese Men to Test How Different Doses of BI 690517 Are Taken Up in the Body and How Well They Are Tolerated
Phase 1Completed 16 Apr 2020 This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated
Phase 1Completed 17 Nov 2022 A Study in Healthy Men to Test How BI 690517 is Taken up and Handled by the Body
Phase 1Completed 13 Apr 2023 A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems
Phase 1Completed 12 Dec 2024 A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood
Phase 1Completed 7 Aug 2025 A Study in Healthy Men to Compare the Amount of Vicadrostat and Empagliflozin in the Blood When Taken Separately and Together
Phase 1Completed 22 Oct 2025 A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood
Phase 1Completed 24 Jul 2026 A Study in Healthy People to Test How Vicadrostat Affects the Heart
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Vicadrostat

Following is part of Solo: you see every change to Vicadrostat the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in